Skip to main content

Peer Review reports

From: ABCG2 is a potential prognostic marker of overall survival in patients with clear cell renal cell carcinoma

Original Submission
4 Nov 2016 Submitted Original manuscript
16 Nov 2016 Author responded Author comments - Juping Zhao
Resubmission - Version 2
16 Nov 2016 Submitted Manuscript version 2
5 Dec 2016 Author responded Author comments - Juping Zhao
Resubmission - Version 3
5 Dec 2016 Submitted Manuscript version 3
28 Feb 2017 Author responded Author comments - Juping Zhao
26 Jan 2017 Reviewed Reviewer Report - Brian Shuch
9 Jan 2017 Reviewed Reviewer Report - Mark Ball
Resubmission - Version 4
28 Feb 2017 Submitted Manuscript version 4
14 Mar 2017 Author responded Author comments - Juping Zhao
Resubmission - Version 5
14 Mar 2017 Submitted Manuscript version 5
Publishing
23 Mar 2017 Editorially accepted
27 Mar 2017 Article published 10.1186/s12885-017-3224-6

You can find further information about peer review here.

Back to article page